The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea

Biochemical Pharmacology

Volumn 61, Issue 12, 2001, Pages 1531-1535

  Boelaert, Johan R ^a   Sperber, Kirk ^b   Piette, Jacques ^c  

^a U for Renal and Infectious Diseases   (Belgium)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chloroquine; Didanosine; HIV 1; Hydroxyurea; Zidovudine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHLOROQUINE; DIDANOSINE; HYDROXYUREA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTI-HIV AGENTS; CHLOROQUINE; DRUG SYNERGISM; HIV-1; HUMANS; HYDROXYUREA; MICROBIAL SENSITIVITY TESTS; ZIDOVUDINE;

EID: 0035877139     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00576-7     Document Type: Article

References (18)

1. Gao W.Y., Cara A., Gallo R.C., Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes a strategy to inhibit HIV-1 replication . Proc Natl Acad Sci USA. 90:1993;8925-8928.
2. Lori F. Hydroxyurea and HIV 5 years later - from antiviral to immune-modulating effects . AIDS. 13:1999;1433-1442.
3. Gao W.Y., Johns D.G., Chokekuchai S., Mitsuya H. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2′,3′-dideoxynucleoside activities against replication of human immunodeficiency virus. Proc Natl Acad Sci USA. 92:1995;8333-8337.
4. Sperber K., Kalb T.H., Stecher V.J., Banerjee R., Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses. 9:1993;91-98.
5. Chiang G., Sassaroli M., Louie M., Chen H., Stecher V.J., Sperber K. Inhibition of HIV-1 replication by hydroxychloroquine mechanism of action and comparison with zidovudine . Clin Ther. 18:1996;1080-1092.
6. Tsai W.P., Nara P.L., Kung H.F., Oroszlan S. Inhibition of human immunodeficiency virus infectivity by chloroquine. AIDS Res Hum Retroviruses. 6:1990;481-489.
7. Pardridge W.M., Yang J., Diagne A. Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes. Immunol Lett. 64:1998;45-47.
8. Sperber K., Louie M., Kraus T., Proner J., Sapira E., Lin S., Stecher V., Mayer L. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther. 17:1995;622-636.
9. Sperber K., Chiang G., Chen H., Ross W., Chusid E., Gonchar M., Chow R., Liriano O. Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with HIV-1. Clin Ther. 19:1997;913-923.
10. Boelaert J.R., Sperber K. Antiretroviral therapy. Lancet. 352:1998;1224-1225.
11. Boelaert J.R., Sperber K., Piette J. Chloroquine exerts an additive in vitro anti-HIV-1 effect, when associated with didanosine and hydroxyurea. AIDS Res Hum Retroviruses. 15:1999;1241-1247.
12. Boelaert JR, Appelberg R, Gomes MS, Blasi E, Mazzolla R, Grosset J, Lounis N, Soteriadou K, Thiakaki M, Taramelli D, Tognazioli C. Experimental results on chloroquine and AIDS-opportunists. J Acquir Immune Defic Syndr Hum Retrovirol 2001; in press.
13. Legssyer R., Ward R., Crichton R.R., Boelaert J.R. Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and oxidative responses by the alveolar macrophages. Biochem Pharmacol. 57:1999;907-911.
14. Boelaert J.R., Weinberg G.A., Weinberg E.D. Altered iron metabolism in HIV infection mechanisms, possible consequences, and proposals for management . Infect Agents Dis. 5:1996;36-46.
15. Sperber K., Quraishi H., Kalb T.H., Panja A., Stecher V., Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells . J Rheumatol. 20:1993;803-808.
16. Picot S., Peyron F., Donadille A., Vuillez J.P., Barbe G., Ambroise-Thomas P. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology. 80:1993;127-133.
17. Augustijns P., Geusens P., Verbeke N. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol. 42:1992;429-433.
18. Boelaert JR, Piette J, Sperber K. The potential place of chloroquine in the treatment of HIV-1 infected patients. J Clin Virol: in press.